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OBJECTIVES This study investigated the combination of maximal and low-intensity exercise testing in
predicting prognosis in chronic heart failure (CHF), using one single exercise test (two-step
protocol).
BACKGROUND Risk assessment based on any single factor has limited accuracy and reproducibility.
METHODS Treadmill exercise testing was performed in 202 consecutive CHF patients (174 male; mean
age 52  11 years) using “breath-by-breath” gas exchange monitoring. Oxygen uptake (VO2)
kinetics were defined as oxygen deficit (VO2  time [rest to steady state]   VO2 [rest to
steady state]) and mean response time (MRT  oxygen-deficit/VO2). Peak VO2 (VO2max)
was defined as the highest VO2. Mean follow-up was 873 628 days. The primary end point
was cardiac mortality and the need for urgent heart transplantation.
RESULTS Forty-four patients (22%) died and 15 (7%) were urgently transplanted. In both univariate
and multivariate analyses, MRT 50 s was the most powerful predictor of the primary end
point (hazard ratio [HR] 4.44), followed by predicted VO2max 50% (HR 3.50) and resting
systolic blood pressure 105 mm Hg (HR 2.49, all p  0.001). A majority (n  130 [64%])
had one or none of these risk factors, with a one-year event rate of only 3%. Patients with two
risk factors (n  45 [22%]) were at medium risk (one-year event rate of 33%). Twenty-seven
patients (13%) had all three risk factors, with a one-year event rate of 59%. The area under
the curve, using the number of risk factors, was 0.86  0.04 for the primary end point at one
year. These results were independent of medication, in particular, beta-blockade.
CONCLUSIONS A combination of low-intensity and maximal exercise test results improves assessment of
prognosis in patients with CHF. (J Am Coll Cardiol 2003;42:116–22) © 2003 by the
American College of Cardiology Foundation
Exercise testing has become a mainstay for the prognostic
assessment of patients with chronic heart failure (CHF) (1).
Various studies have shown that patients with impaired
exercise capacity, as measured by low peak oxygen consump-
tion (VO2), have an unfavorable outcome, independent of
other parameters (2). However, risk assessment based on
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any single factor has limited accuracy and reproducibility.
Therefore, prognostic scores, including various clinical and
hemodynamic parameters, were introduced to improve pre-
diction of outcome in CHF (3).
Recent studies have investigated whether ventilatory and
gas exchange responses other than peak VO2 (VO2max) may
have prognostic value (4,5) or tried to substitute peak
exercise testing by submaximal tests (6). Thus, assessment of
VO2 kinetics at low-intensity exercise differed between heart
failure patients with poor versus preserved left ventricular
function, whereas VO2max did not (7). Because VO2 kinetics
and VO2max appear to provide physiologically different
information, we wondered whether a combination of pa-
rameters obtained at low intensity as well as maximal
exercise testing in the same test may provide a more
complete risk assessment in CHF patients.
METHODS
A total of 219 consecutive CHF patients referred to our
CHF clinic with a left ventricular ejection fraction 40%
were considered for this study. Of these, 17 (8%) did not
tolerate spirometry during exercise or had technically inad-
equate recordings. Thus, 202 patients form the basis for this
report. Patients with complex congenital heart disease,
CHF with a preserved ejection fraction, or decompensated
heart failure were not included in the study. Patients were
also excluded if either severe pulmonary or orthopedic
disease limited their exercise capacity (5% of the entire
population referred to our clinic). Correctable causes of
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CHF were treated before inclusion in the study. Conditions
had to be stable for at least two months.
The cause of CHF was coronary artery disease in 106
(53%), dilated cardiomyopathy in 69 (34%), valvular disease
in 5 (2%), hypertension in 4 (2%), and other or combined
cardiac etiologies in 18 (9%). All but two patients (99%)
were taking either an angiotensin-converting enzyme inhib-
itor or an angiotensin II receptor blocker, 182 (90%) were
on diuretics, 100 (50%) on digitalis, 91 (45%) on beta-
blockers, 45 (22%) on nitrates, and 47 (23%) on amioda-
rone. One hundred forty-eight patients (73%) were receiv-
ing oral anticoagulation, 25 (12%) aspirin, and 11 (5%) both
drugs.
All patients were assessed clinically and had a standard
multipanel laboratory screening. Subsequently, a treadmill
exercise test was performed. Other diagnostic tests, such as
right heart catheterization and radiography, were performed
according to the discretion of the treating physicians.
Because these data are not complete, they were not included
in the analysis.
Gas exchange was assessed breath by breath, using a
CPX/D system (Medical Graphics Corp., St. Paul, Minne-
sota), calibrated before each test. There was no familiariza-
tion test before the study, but patients were carefully
instructed about how to walk on the treadmill and became
familiarized with breathing connected to the spirometry
system. Patients started walking after reaching steady-state
gas exchange while standing quietly. A two-step protocol
was used (8). Initially, they walked at 1.0 mph with an
elevation of 6% for 6 min, corresponding to 	0.5 W/kg
body weight. Thereafter, both speed and elevation were
increased to augment workload by 	0.15 W/kg body
weight per minute until exhaustion. Workload was assessed
by rearrangement of the formula by the American College
of Sports Medicine (9):
Work load  (elevation 
 5.5%)  speed  g [1]
where elevation is expressed in %, speed in m/s (i.e., mph 
1,609/3,600), and g as the gravitation constant (i.e., 9.81).
The oxygen deficit was calculated according to the
formula (8):
Oxygen deficit  t  VO2  VO2 [2]
where t is the time from rest to steady state (min); VO2 is
the difference in oxygen uptake between rest and steady
state (ml/min); and VO2 is the sum of consumed oxygen
(ml). To calculate the oxygen deficit, software called
BreezeEx, version 3.02 (Medical Graphics Corp.) was used.
The mean response time of oxygen uptake (MRT; i.e.,
the time constant of oxygen uptake) was calculated using the
formula (10):
MRT 
O2  deficit
VO2
[3]
Peak VO2 was defined as the highest VO2 by averaging five
of seven consecutive breaths during any stage. In most
instances, this corresponded to the highest workload that
was sustained for 1 min (i.e., peak work load). Peak VO2 is
reported after correction for body weight (ml/min/kg) and
as a percentage of predicted normal values accounting for
age, height, weight, and gender (11). The ventilatory
response to exercise (VE/VCO2) was defined as previously
described (12). One case of nonsustained ventricular tachy-
cardia occurred immediately after the test.
General practitioners were primarily responsible for the
care of the patients. However, all surviving patients had
structured follow-up visits in our clinic. Patient status was
determined by one of us (Dr. Rickli) by interviewing
referring physicians and/or patients and by chart review,
without knowledge of other patient data. A cardiac cause of
death was assumed if the patient either died with symptoms
of progressive CHF or died suddenly. One patient commit-
ted suicide and his follow-up was censored at the time of the
event. No other noncardiac deaths were noted. Urgent
transplantation, defined by the need for intensive care
treatment with positive inotropic agents or a left ventricular
assist device (LVAD), was considered as the primary end
point. Patients were listed for elective transplantation ac-
cording to the judgment of the treating physicians, based on
clinical data, hemodynamics, and ergospirometry. There-
fore, elective transplantation was not considered as an end
point and follow-up was censored at that time.
Statistical analysis. Data are expressed as the mean value
 SD and frequencies, as indicated. Survival and survival
free of urgent transplantation were calculated using Kaplan-
Meier curves. The hazard ratio (HR) was assessed by
univariate Cox regression analysis. Multivariate Cox regres-
sion analysis was performed, including significant predictors
of outcome in the univariate analysis in a stepwise manner,
accounting for potential interrelations between variables. An
unadjusted multivariate model was used as well as a model
adjusted for age, gender, and ejection fraction. Because both
models provided identical results, only the unadjusted
model is presented.
Receiver operating characteristics curves for one-year
survival and the primary end point of survival free of urgent
transplantation were analyzed by nonparametric Z statistics.
Statistical analysis was performed using the software pack-
age SPSS, version 9.0 (SPSS Inc., Chicago, Illinois).
Abbreviations and Acronyms
BP  blood pressure
CHF  chronic heart failure
HR  hazard ratio
LVAD  left ventricular assist device
MRT  mean response time of oxygen uptake at
onset of exercise
VE/VCO2  ventilatory response to exercise
VO2  oxygen consumption
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RESULTS
Baseline characteristics are listed in Table 1. Forty-four
patients (22%) died from a cardiac cause and 15 (7%)
needed urgent transplantation (mean follow-up 873  628
days; median 737 days). Another 15 patients underwent
elective heart transplantation.
Table 2 shows significant predictors of outcome in the
univariate analysis. The most significant predictor of all end
points was MRT. The predictive value of VO2max was
better if it was normalized to the predicted value rather than
just body weight.
Stepwise multivariate Cox regression analysis yielded
MRT, percent predicted VO2max, and resting systolic blood
pressure (BP) as independent predictors of outcome (Table
3). These independent predictors of outcome were ex-
pressed as dichotomous variables to separate patients into
low-, medium-, and high-risk groups. Thus, patients with
MRT 50 s (HR 4.44 for the primary end point and HR
3.52 for cardiac mortality; p  0.001), VO2max 50% of
the predicted value (HR 3.29 and 2.96, respectively; p 
0.001), and resting BP 105 mm Hg (HR 2.49 and 2.25,
respectively; p  0.01) were at particular risk of a poor
outcome. Importantly, MRT predicted outcome in patients
with percent predicted VO2max 50% and 50% (Fig. 1).
Table 1. Baseline Characteristics
Total Population
(n  202)
MRT <50 s
(n  115)
MRT >50 s
(n  87)
Age (yrs) 52  11 53  11 50  10
Gender (M/F) 174/28 103/12 71/16
NYHA functional class (I/II/III/IV) 7/101/90/4 3/69/42/1 4/32/48/4*
Sinus rhythm (%) 173 (86) 106 (92) 67 (77)*
Left ventricular ejection fraction (%) 28  7 28  7 28  7
Resting heart rate (beats/min) 82  17 81  18 83  16
Resting systolic BP (mm Hg) 103  17 105  17 100  17†
Peak VO2 (ml/kg/min) 19.3  5.5 20.7  5.6 17.5  4.9‡
Peak VO2 (% predicted maximum) 63.6  20.6 68.7  21.3 56.9  17.6‡
Peak heart rate (beats/min) 135  26 138  26 130  26†
Peak systolic BP (mm Hg) 127  28 134  26 118  29‡
Ventilatory response (VE/VCO2 slope) 35.9  7.0 33.9  5.5 38.5  7.9‡
Respiratory exchange ratio at peak 1.12  0.12 1.11  0.12 1.12  0.11
Oxygen deficit (ml/kg) 5.6  2.0 4.7  1.5 6.8  1.8‡
Mean response time (s) 49.3  13.1 40.2  7.2 61.4  8.6‡
VO2 at low-intensity exercise (ml/kg/min) 10.8  1.8 10.9  1.8 10.6  1.8
Steady state reached (%) 175 (87) 112 (97) 63 (72)‡
Peak work load (W/kg) 1.51  0.59 1.67  0.60 1.31  0.52‡
Serum sodium (mmol/l) 138.5  3.4 139.1  3.1 137.7  3.6*
Serum creatinine (mmol/l) 113  33 106  21 123  43*
*p  0.05, †p  0.01, ‡p  0.0001 between patients with MRT 50 and 50 s. Data are presented as the mean value  SD
or number (%) of subjects.
BP  blood pressure; F  female; M  male; MRT  mean response time of oxygen uptake at onset of exercise; NYHA
 New York Heart Association; VO2  oxygen consumption.
Table 2. Univariate Predictors of Primary End Point of Cardiac Mortality and Need for Urgent
Heart Transplantation
Primary End Point Cardiac Mortality
HR 95% CI p Value HR 95% CI p Value
Mean response time (10 s) 1.69 1.43–2.00  0.001 1.64 1.35–2.00  0.001
Exercise systolic BP (10 mm Hg) 0.74 0.66–0.82  0.001 0.74 0.65–0.85  0.001
Peak VO2 % predicted (10%) 0.67 0.56–0.78  0.001 0.69 0.57–0.83  0.001
VE/VCO2 (10 U) 1.92 1.45–2.54  0.001 1.91 1.38–2.64  0.001
Exercise capacity % predicted (10%) 0.77 0.69–0.86  0.001 0.80 0.70–0.91  0.001
Oxygen deficit (ml/kg) 1.22 1.10–1.34  0.001 1.22 1.09–1.37  0.001
Peak VO2 (ml/kg/min) 0.90 0.85–0.95  0.001 0.89 0.83–0.95  0.001
Sinus rhythm 0.39 0.21–0.70 0.002 0.34 0.17–0.66 0.002
Serum sodium (mmol/l) 0.88 0.82–0.95 0.002 0.91 0.83–1.00 0.06
Resting systolic BP (10 mm Hg) 0.75 0.63–0.90 0.002 0.80 0.65–0.98 0.04
Serum creatinine (10 mol/l) 1.11 1.04–1.19 0.003 1.13 1.04–1.22 0.003
NYHA functional class 1.89 1.14–3.14 0.02 — — NS
Exercise heart rate (10 beats/min) 0.89 0.82–0.99 0.02 0.89 0.79–0.99 0.03
Order of variables is according to significance regarding primary end point. Variables not significantly related to outcome are not
shown.
CI  confidence interval; HR  hazard ratio; other abbreviations as in Table 1.
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One hundred thirty patients (64%) had none or only one
of these risk factors. These patients had a good prognosis
(Fig. 2), whereas patients with two risk factors (n  45
[22%]) were at medium risk of a poor outcome. Twenty-
seven patients (13%) had all three of these risk factors.
These patients were at high risk, with a one-year mortality
rate of 50% (Figs. 2 and 3). The area under the curve, using
the number of risk factors, was 0.86 0.04 (95% confidence
interval [CI] 0.78 to 0.94) for the primary end point at one
year and 0.83 0.05 for one-year cardiac mortality (95% CI
0.75 to 0.92; both p  0.0001). Risk assessment was not
superior using the score of Aaronson et al. (3), as compared
with the model described herein.
Because of the known impact of beta-blockade on prog-
nosis, patients were separated into those with and without
beta-blockade. Apart from the expected trend in heart rate
(at rest: 80 17 vs. 84 16 beats/min, p 0.11; peak: 131
 27 vs. 138  25 beats/min, p  0.05), baseline charac-
teristics did not differ between patients with and without
beta-blockade. Patients treated with beta-blockers had a
better outcome than those without (primary end point HR
0.56, p  0.05; cardiac mortality HR 0.51, p  0.06), but
the number of risk factors still predicted the outcome in
both subgroups (Fig. 4). Importantly, high-risk patients had
an equally poor outcome, irrespective of whether they were
on beta-blockers or not (p  0.8). The incremental value of
each of the three risk factors to predict outcome did not
differ between those treated with beta-blockers and those
without.
DISCUSSION
This study suggests that the combination of parameters
obtained at the beginning of and during maximal exercise
testing may be helpful in assessing prognosis in CHF. The
prognostic information of low-intensity and maximal exer-
Table 3. Predictors of Primary End Point and Cardiac Mortality in Multivariate Cox Regression
Analysis
Primary End Point Cardiac Mortality
HR 95% CI p Value HR 95% CI p Value
Mean response time (10 s) 1.67 1.38–2.01  0.001 1.60 1.29–1.99  0.001
Peak VO2 % predicted (10%) 0.71 0.60–0.85  0.001 0.73 0.60–0.89 0.002
Resting systolic BP (10 mm Hg) 0.77 0.64–0.92 0.005 0.82 0.66–1.00 0.05
Abbreviations as in Tables 1 and 2.
Figure 1. Survival free of urgent transplantation (TPL) in patients with
relatively preserved (top; VO2max 50%) and reduced (bottom; VO2max
50%) peak exercise capacity in relation to oxygen uptake kinetics at start
of low-intensity exercise (mean response time of oxygen uptake at onset of
exercise 50 and 50 s).
Figure 2. Survival free of (A) urgent transplantation (TPL) and (B) cardiac
survival in relation to the number of risk factors (mean response time of
oxygen uptake at onset of exercise 50 s, VO2max 50%, resting systolic
blood pressure 105 mm Hg).
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cise testing was comparable to previously described complex
scores for prognostic assessment in CHF patients (3,13),
but was obtainable with one single exercise test. Impor-
tantly, a relatively small subgroup of patients (13%) with a
50% one-year mortality rate could be identified, whose poor
prognosis was independent of treatment with beta-blockers.
These patients may be candidates for heart transplantation
or LVAD implantation.
During the last two decades, medical therapy has pro-
gressed significantly (14), thereby reducing the generally
accepted survival benefit of heart transplantation. Further-
more, a shortage of organ donors limits its therapeutic
potential (15). Therefore, identification of patients who
profit most from heart transplantation is essential (16).
Recently, survival benefits have been described with the use
of LVAD in patients with a very poor prognosis (17).
However, the adverse effects and cost of these devices are
enormous, highlighting the importance of identification of
CHF patients with the poorest prognosis.
During the last decade, numerous studies have assessed
prognosis in CHF. Various parameters have been found to
be related to outcome in CHF (3,9). Among them, the
results of cardiopulmonary exercise testing has gained wide-
spread acceptance (18). Early results have shown that
VO2max 14 ml/kg/min identifies patients with severe
CHF who benefit from heart transplantation, whereas in
those with VO2max 14 ml/kg/min, transplantation could
be safely deferred (1). As VO2max is affected by age, gender,
and stature, the percent predicted VO2max, rather than only
the weight-adjusted value, may be superior in predicting
survival. This approach, however, added only minimal
prognostic information in some studies (19), whereas our
study and previous data (20) suggest that a cutoff point of
50% of predicted VO2max was the best value. This discrep-
ancy may be explained, at least in part, by the inclusion of
differing patient populations and the use of different exercise
protocols.
Individual assessment based on any single factor has
limited accuracy and reproducibility (3). Thus, CHF pa-
tients in stable conditions were found to have a two-year
survival rate as good as 86%, despite significantly reduced
VO2max of 12.3  1.5 ml/kg/min (21). On the other hand,
the annual mortality rate may be up to 10%, even in patients
with preserved exercise capacity (22). Thus, there is a need
for further risk stratification in addition to measurement of
VO2max. Various studies incorporated other parameters to
improve risk stratification (19). However, only a few studies
have tried to integrate parameters other than VO2max in the
same exercise test (23,24). Moreover, in CHF patients with
preserved exercise capacity, an enhanced ventilatory re-
sponse at peak exercise predicted a poor prognosis and
added independent prognostic information to VO2max
(23,25). However, this differs from studies in which the
ventilatory response at a submaximal workload provided no
prognostic information to VO2max (26). Previously, at-
tempts have also been made to substitute VO2max with
parameters obtained during submaximal exercise tests (6).
However, a correlation of VO2max to parameters of sub-
maximal exercise tests was often only moderate (8,26–28)
and was particularly poor in patients with an intermediate
VO2max value (10 to 20 ml/kg per min) (r  0.28) (28).
This may not be surprising, as low-intensity exercise and
peak exercise represent different cardiopulmonary responses
in terms of the increment of cardiac output and ventilatory
response (7). At the start of exercise, stroke volume increases
first, and a further increase in cardiac output predominantly
depends on an increase in heart rate (11). In CHF,
chronotropic incompetence is common and related to a poor
outcome, but not independent of VO2max. Thus, altered
VO2max may be influenced primarily by the heart rate
response, whereas VO2 kinetics at low-intensity exercise are
primarily influenced by changes in pump function. Our data
suggest that the prognostic value of VO2 kinetics at low-
Figure 3. Percentage of end points after one year in relation to the number
of risk factors (for definition, see Fig. 1). Solid bar 0 or 1 risk factor; bar
with diagonal lines  2 risk factors; dotted bars  3 risk factors.
Figure 4. Survival free of urgent transplantation (TPL) stratified by the
number of risk factors in patients (A) without and (B) with beta-blockade.
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intensity exercise is complementary to VO2max, and that
this may still be true, even if the heart rate response is
altered by beta-blockade.
Additionally, we found resting systolic BP to be an
independent predictor of prognosis. The relationship be-
tween low resting systolic BP and an adverse outcome was
found in some but not all previous studies (3,24).
A number of models have been developed for improved
risk stratification of patients considered for transplantation
(3,29). Our study shows that powerful risk stratification may
be possible with the use of one simple test using a two-step
protocol. Combining low-intensity and maximal exercise
testing is quick and inexpensive and does not require the
patient to undergo additional testing. The data indicate that
prognosis is very poor in patients with prolonged oxygen
kinetics, low VO2max, and low resting BP. The one-year
mortality rate was 50% in this minority of patients (13%). In
all other groups, the prognosis was not substantially differ-
ent from what would have been expected in transplanted
patients or those who had LVAD implantation. Patients
with two of these risk factors may, however, deserve close
monitoring for potential listing for transplantation.
Study limitations. Some limitations apply to the present
study. The percentage of women was low (14%). Peak VO2
has been described to be gender-related, and it is unknown
whether this also applies to VO2 kinetics in female patients
with CHF. Also, the data were derived from patients
referred for evaluation of possible heart transplantation.
Accordingly, the results may not apply to less severely
affected patients. However, their prognosis usually is better
and the need for risk assessment less urgent.
Peak VO2, MRT, and BP are continuous variables;
therefore, it is difficult to define a single cutoff value beyond
which risk of an event is considered high. Data from
different studies examining populations of patients with
different severities of heart failure have yielded various
thresholds of VO2max (30). However, stratifying patients
above and below VO2max of 50% of predicted maximum has
demonstrated marked differences in survival in this and
other studies (19). We have chosen a cutoff value of 50 s for
MRT, which lies between the previously proposed values of
40s and 60s (31). The BP cutoff value was chosen to
separate patients into approximately equally large sub-
groups. Using other cutoff values did not change our model.
There was no familiarization test before the study, which
may lead to slightly lower VO2max (11). However, inclusion
of a second test, which has been performed in 	60% of
patients, did not influence the results (data not shown).
Also, some of the sick patients did not reach steady state
during low-intensity exercise, thereby prolonging MRT.
However, this did not influence the prognostic value, as
these patients were correctly classified.
Advances in medical therapy have significantly improved
the prognosis in CHF patients. Thus, prognostic scores
based on patient populations not treated with current
therapeutic regimens may no longer be valid. Exercise
testing had a prognostic impact, irrespective of whether
patients were on or off beta-blockade (32). However, the
prognosis of high-risk patients on beta-blockade was not
worse than that of transplant candidates off beta-blockers,
thus questioning the use of peak exercise testing for heart
transplantation listing. We confirmed a better prognosis in
patients receiving beta-blockers. However, the improve-
ment in prognosis was primarily found in low- to medium-
risk patients. The high-risk subgroup defined in this study
did not benefit from beta-blocker therapy. Still, it must be
pointed out that the number of high-risk patients classified
into subgroups was small, and larger studies are needed to
better define the prognostic impact of our model in patients
receiving beta-blockade as well as angiotensin-converting
enzyme inhibition. Importantly, other drug therapy did not
influence the outcome or predictive power of our model
(data not shown).
We used a protocol with a fixed treadmill speed and
elevation rather than a fixed workload. Protocols for tread-
mill exercise testing generally use steps with fixed speed and
elevation, and adjusting our results for body weight did not
have any influence. Nevertheless, methodologic differences
make a direct comparison between our present study and
previous studies difficult, as may the lack of an accepted
standard for assessment of VO2 kinetics. One could specu-
late that the higher the workload, the more oxygen kinetics
become heart rate-dependent. This may explain why the
correlation between MRT and VO2max is better with a
higher (33) than with lower workload (27,31,34).
Conclusions. The combination of BP and parameters of
low-intensity and maximal exercise testing allows better risk
assessment of CHF patients, as compared with assessment
based on any single factor. Patients with a delayed increase
in VO2 at the onset of exercise, low VO2max (expressed as
percent of predicted maximum), and low resting systolic BP
are at a particularly high risk. The two-step exercise protocol
test employed in this study is quick and no more expensive
than determination of VO2max alone. Prospective applica-
tions of the score will be required to assess its clinical value
for risk assessment of CHF patients. Furthermore, it is
obvious that a risk score such as the one provided here must
be used in the clinical context of each individual patient
only.
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